Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sugo
    Junior Member
    • Nov 2013
    • 8

    Visualizing Bowtie results in Galaxy

    Hello,

    I have just done my very first run of bowtie, via galaxy. I want to get an idea of whether it worked at all... but I have no idea what the output means! Anyone know of a good link(s) to explain the galaxy output of bowtie?

    When I click the little 'view data' button, I get an output like this:

    QNAME FLAG RNAME POS MAPQ CIGAR MRNM MPOS ISIZE SEQ QUAL OPT
    @HD VN:1.0 SO:unsorted
    @SQ SN:chr2 LN:30794189
    @SQ SN:chr3 LN:19779522
    @SQ SN:chr4_group4 LN:6586962

    I know that QNAME etc. describe various features of the output, but I don't know what exactly they mean or how they may or may not be linked to the many lines of text that come after them (the first four of which I've included here... and which after about 16 lines all look something like this one: @SQ SN:Unknown_group_1 LN:174220).

    I also tried to visualize the data through Trackster, but I'm getting this error:

    "The page at https://usegalaxy.org says: Could not load chroms for this dbkey"

    It seems to me that this is an error with galaxy and the reference genome (which is one of the built-in references), but I don't know how to go about resolving it.

    Thanks in advance for any advice.
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Are you using a local mirror of galaxy or the public install at PSU?

    Comment

    • sugo
      Junior Member
      • Nov 2013
      • 8

      #3
      I'm using the main galaxy server, as far as I know (https://usegalaxy.org).

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 11:41 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...